Tregalizumab
Product Specifications
CAS Number
1207446-68-1
Target
Immunology/Inflammation related
Related Pathways
Immunology/Inflammation
Purity
0.99
Bioactivity
Tregalizumab (BT-061) is a humanised monoclonal antibody targeting CD4, capable of binding unique epitopes on CD4 and selectively inducing regulatory T cell (Treg) activation. It holds potential applications in immunology and inflammation.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1294757-01 0.02 mg (E-Coli)
Recombinant Coxiella burnetii Oligoribonuclease (orn)
Ask
View Details 
MBS1294757-02 0.1 mg (E-Coli)
Recombinant Coxiella burnetii Oligoribonuclease (orn)
Ask
View Details 
MBS1294757-03 0.02 mg (Yeast)
Recombinant Coxiella burnetii Oligoribonuclease (orn)
Ask
View Details 
MBS1294757-05 0.02 mg (Baculovirus)
Recombinant Coxiella burnetii Oligoribonuclease (orn)
Ask
View Details MBS1294757-06 0.02 mg (Mammalian-Cell)
Recombinant Coxiella burnetii Oligoribonuclease (orn)
Ask
View Details